Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Receives Consensus Recommendation of “Hold” from Brokerages

Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) have been assigned a consensus recommendation of “Hold” from the sixteen research firms that are presently covering the company, MarketBeat.com reports. Two equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating and seven have issued a buy rating on the company. The average twelve-month price objective among brokerages that have updated their coverage on the stock in the last year is $21.1538.

Several research analysts recently commented on ACHC shares. Mizuho cut their price objective on shares of Acadia Healthcare from $22.00 to $17.00 and set a “neutral” rating for the company in a report on Thursday, December 18th. Bank of America cut shares of Acadia Healthcare from a “neutral” rating to an “underperform” rating and lowered their target price for the company from $21.50 to $13.00 in a report on Wednesday, December 3rd. Guggenheim dropped their target price on Acadia Healthcare from $27.00 to $22.00 and set a “buy” rating on the stock in a research report on Monday, February 23rd. Zacks Research upgraded Acadia Healthcare from a “strong sell” rating to a “hold” rating in a research report on Thursday, March 5th. Finally, Cantor Fitzgerald set a $17.00 price objective on Acadia Healthcare in a research note on Wednesday, December 3rd.

Institutional Investors Weigh In On Acadia Healthcare

Institutional investors and hedge funds have recently modified their holdings of the company. Wellington Management Group LLP boosted its stake in Acadia Healthcare by 24.9% during the fourth quarter. Wellington Management Group LLP now owns 11,774,308 shares of the company’s stock valued at $167,077,000 after buying an additional 2,350,760 shares during the period. Vanguard Group Inc. boosted its position in shares of Acadia Healthcare by 7.8% during the 3rd quarter. Vanguard Group Inc. now owns 9,417,045 shares of the company’s stock valued at $233,166,000 after acquiring an additional 681,278 shares during the last quarter. Goldman Sachs Group Inc. grew its holdings in shares of Acadia Healthcare by 417.8% during the fourth quarter. Goldman Sachs Group Inc. now owns 4,728,613 shares of the company’s stock worth $67,099,000 after purchasing an additional 3,815,471 shares in the last quarter. Abrams Bison Investments LLC increased its position in shares of Acadia Healthcare by 22.3% in the third quarter. Abrams Bison Investments LLC now owns 4,380,000 shares of the company’s stock worth $108,449,000 after purchasing an additional 800,000 shares during the last quarter. Finally, UBS Group AG increased its position in shares of Acadia Healthcare by 8.8% in the third quarter. UBS Group AG now owns 4,336,698 shares of the company’s stock worth $107,377,000 after purchasing an additional 350,484 shares during the last quarter.

Acadia Healthcare Trading Down 1.0%

Shares of ACHC opened at $22.73 on Friday. Acadia Healthcare has a fifty-two week low of $11.43 and a fifty-two week high of $31.04. The business has a 50-day moving average of $17.71 and a 200 day moving average of $18.77. The firm has a market cap of $2.10 billion, a P/E ratio of -1.86, a price-to-earnings-growth ratio of 7.68 and a beta of 0.74. The company has a debt-to-equity ratio of 1.27, a quick ratio of 1.55 and a current ratio of 1.55.

Acadia Healthcare (NASDAQ:ACHC) last released its quarterly earnings data on Wednesday, February 25th. The company reported $0.07 EPS for the quarter, beating the consensus estimate of $0.03 by $0.04. The business had revenue of $821.46 million for the quarter, compared to the consensus estimate of $800.10 million. Acadia Healthcare had a negative net margin of 33.29% and a positive return on equity of 6.53%. The company’s revenue was up 6.1% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.64 earnings per share. Acadia Healthcare has set its FY 2026 guidance at 1.300-1.550 EPS and its Q1 2026 guidance at 0.250-0.300 EPS. As a group, research analysts forecast that Acadia Healthcare will post 3.38 EPS for the current year.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.